Featured News

Devex featured an opinion piece from GHTC Director Jamie Bay Nishi highlighting the need for innovative, technological solutions to end the epidemic of malaria. It also highlights the incredible successes of R&D in response to the epidemic.

Learn More
GHTC, PATH, GHC
GHTC delivers statement on WHO R&D observatory, pooled fund at WHA

GHTC delivered a statement at the 70th World Health Assembly (WHA) calling for the rapid operationalization and full funding for the World Health Organization Global Observatory on Health Research and Development and supporting efforts to establish a health R&D pooled fund. The statement, which was issued in partnership with the Global Health Council and PATH, also encourages exploration of innovative funding sources to attract new funding for the observatory and pooled fund and calls for continued transparency to ensure these operations are grounded in sound science and public health.

PDF
PATH/Gabe Bienczycki
IP Watch covers GHTC co-hosted event

IP Watch covered the May 22 WHA side-event entitled "Investing in Innovative Health R&D Tools to Address Antimicrobial Resistance and Achieve the SDGs" hosted by GHTC, COHRED, PATH, TB Alliance, MMV, and GHC.

PDF
GHTC, GHC, PATH, American Academy of Pediatrics
GHTC delivers statement on antimicrobial resistance at WHA

GHTC delivered a statement at the 70th World Health Assembly (WHA) welcoming global political commitments to combat antimicrobial drug resistance (AMR) and calling for these efforts to prioritize R&D for new tools. The statement, which was issued in partnership with the Global Health Council, PATH, and the American Academy of Pediatrics, also welcomes the establishment of the Global Antimicrobial Surveillance System and urges WHO to monitor progress by member states in implementing national AMR actions plans to promote accountability.

PDF
GHTC, PATH, GHC
GHTC delivers statement on R&D for epidemic disease at WHA

GHTC delivered a statement at the 70th World Health Assembly (WHA) highlighting the critical role new tools play in epidemic preparedness. The statement, issued in partnership with the Global Health Council and PATH, calls on the World Health Organization and member states to support regulatory capacity building and harmonization efforts, as well as coordinated approaches to develop new technologies through entities like the Coalition for Epidemic Preparedness.

PDF
PATH/Jean-Pierre Leguillou
GHTC director profiled in Impact Magazine

GHTC Director Jamie Bay Nishi was profiled in an article by Impact Magazine, covering challenges facing global health research and development (R&D) and the coalition's efforts to better inform policy makers. 

PDF
View All News
PATH/Gabe Bienczycki
Global health coalition urges G20 pledge on pandemics and neglected diseases

A coalition of global health organizations, including GHTC, has called on the G20 to provide leadership in combating pandemics, drug resistance, and major poverty-related and neglected diseases.

Learn More
Devex
Global Health Technologies Coalition appoints new director

GHTC has named Jamie Bay Nishi as its new director. Currently, Ms. Nishi serves as Managing Director of Devex LIVE at Devex, a media platform for the global development community. She will assume the GHTC director position in late February.

Learn More
From AIDS to Zika, new report warns stagnant US funding for lifesaving tools against infectious disease threats leaves US and world at serious risk

Even as Congress grapples with the White House on how to fund an emergency response to fight Zika virus, a new report from GHTC warns that overall underfunding for development of lifesaving tools against neglected global diseases is putting the United States and the world at risk, and that emergency funding can’t be allowed to substitute for sustained US investment in research and development (R&D) of global health technologies.

Learn More
GHTC to host 4/19 Congressional briefing to unveil policy report

GHTC will launch its seventh annual policy report at an April 19 briefing on Capitol Hill. Some of the leading voices in global health will discuss policy actions the US government can take to accelerate development of urgently-needed tools to tackle existing and emerging health challenges, meet global health goals, and prepare today for the epidemics of tomorrow.

Learn More
Global Health Council joins GHTC

GHTC is excited to announce that the Global Health Council (GHC) has joined the coalition. GHC is the leading membership organization supporting and connecting advocates, implementers, and stakeholders around global health priorities worldwide.

Learn More
View All Announcements
Photo: White house/Shealah Craighead
Medical research, global health programs face steep cuts in Trump budget

On Tuesday, the Trump Administration released its full fiscal year 2018 budget proposal. This budget proposes significant cuts to programs that support global health and medical research at the National Institutes of Health, Centers for Disease Control and Prevention, and the US Agency for International Development.

Read More
CDC/Dr. Scott Smith
G20 health ministers pledge support for R&D to combat antimicrobial resistance, pandemic threats

Health ministers from G20 nations, meeting for the first time, pledged to work together to combat antimicrobial resistance and improve pandemic preparedness, emphasizing the critical role research and development plays in confronting these global challenges.

Read More
PATH/Rocky Prajapati
Research Roundup: Potential malaria and Ebola vaccines and the polio vaccine shortage

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
U.S. Mission Photo/Eric Bridiers
Who will lead WHO and what to watch at WHA

With the 70th World Health Assembly (WHA) commencing next week, GHTC takes a look at what's on the agenda and how it could impact global health R&D.

Read More
PATH/Eric Becker
Research Roundup: The rise of drug-resistant TB, ecosystems and pandemics, and a UN-made global mosquito tracker

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
View Breakthroughs Blog
PATH/Gabe Bienczycki
IP Watch covers GHTC co-hosted event

IP Watch covered the May 22 WHA side-event entitled "Investing in Innovative Health R&D Tools to Address Antimicrobial Resistance and Achieve the SDGs" hosted by GHTC, COHRED, PATH, TB Alliance, MMV, and GHC.

PDF
PATH/Jean-Pierre Leguillou
GHTC director profiled in Impact Magazine

GHTC Director Jamie Bay Nishi was profiled in an article by Impact Magazine, covering challenges facing global health research and development (R&D) and the coalition's efforts to better inform policy makers. 

PDF
PATH/Eric Becker
Devex features GHTC, partners' G20 "Call to Action"

Devex featured the "Call to Action" co-drafted by GHTC, urging G20 leaders to commit political and financial resources as well as expertise to science, technology and innovation in global health.

View
PATH/Aaron Joel Santos
Devex features G20 "Call to Action" co-developed by GHTC

Devex featured the "Call to Action" co-developed by GHTC and other members, urging the G20 to invest in tools and innovations to combat global issues, such as pandemics, poverty-related and neglected diseases (PRNDs), and antimicrobial resistance (AMRs). The report also highlights the events at the G20 health innovation meeting in Berlin, Germany on April 28. 

View
PATH/Gabe Bienczycki
The Guardian features Call to Action co-drafted by GHTC

The Guardian featured the "Call to Action" co-drafted by GHTC and partners, urging the G20 to commit long-term investment to pandemic preparedness, poverty related and neglected diseases (PRNDs) and antimicrobial resistance (AMR).
 

View
View All GHTC in the Media
GHTC, PATH, GHC
GHTC delivers statement on WHO R&D observatory, pooled fund at WHA

GHTC delivered a statement at the 70th World Health Assembly (WHA) calling for the rapid operationalization and full funding for the World Health Organization Global Observatory on Health Research and Development and supporting efforts to establish a health R&D pooled fund. The statement, which was issued in partnership with the Global Health Council and PATH, also encourages exploration of innovative funding sources to attract new funding for the observatory and pooled fund and calls for continued transparency to ensure these operations are grounded in sound science and public health.

PDF
GHTC, GHC, PATH, American Academy of Pediatrics
GHTC delivers statement on antimicrobial resistance at WHA

GHTC delivered a statement at the 70th World Health Assembly (WHA) welcoming global political commitments to combat antimicrobial drug resistance (AMR) and calling for these efforts to prioritize R&D for new tools. The statement, which was issued in partnership with the Global Health Council, PATH, and the American Academy of Pediatrics, also welcomes the establishment of the Global Antimicrobial Surveillance System and urges WHO to monitor progress by member states in implementing national AMR actions plans to promote accountability.

PDF
GHTC, PATH, GHC
GHTC delivers statement on R&D for epidemic disease at WHA

GHTC delivered a statement at the 70th World Health Assembly (WHA) highlighting the critical role new tools play in epidemic preparedness. The statement, issued in partnership with the Global Health Council and PATH, calls on the World Health Organization and member states to support regulatory capacity building and harmonization efforts, as well as coordinated approaches to develop new technologies through entities like the Coalition for Epidemic Preparedness.

PDF
GHTC
GHTC issues statement on WHO R&D observatory, pooled fund at HHS WHA listening session

GHTC issued a statement at the US Department of Health and Human Services (HHS) World Health Assembly (WHA) Stakeholder Listening Session supporting the rapid establishment and full funding for the World Health Organization (WHO) Global Observatory on Health Research and Development, as well as ongoing efforts to establish a pooled fund. The statement, issued with PATH, also calls for transparency to ensure the fund’s foundation is sound science and public health.

PDF
GHTC
GHTC issues statement on antimicrobial resistance at HHS WHA listening session

GHTC issued a statement at the US Department of Health and Human Services (HHS) World Health Assembly (WHA) Stakeholder Listening Session welcoming the World Health Organization’s (WHO) efforts to combat antimicrobial drug resistance (AMR). The statement, issues with PATH, calls on the US government to support these efforts, with a focus on prioritizing development of a range of new tools, as well as to support the establishment of the Global Antimicrobial Surveillance System.

PDF
View All Advocacy Actions

Events

Community Event

McGill University
McGill Summer Institute in Infectious Diseases and Global Health
McGill University
Learn More
View All Current & Past Events

Stay Informed

Sign up to receive news and updates from GHTC.
Sign Up Now

Media Inquiries

Marissa Chmiola
Communications Officer
Global Health Technologies Coalition
mchmiola@ghtcoalition.org